Barrett's esophagus: Proton pump inhibitors and chemoprevention II

Joel E. Richter, Roberto Penagini, Daniel Pohl, Katerina Dvorak, Aaron Goldman, Edoardo Savarino, Patrizia Zentilin, Vincenzo Savarino, Joshua T. Watson, Roy K H Wong, Fabio Pace, Valentina Casini, David A. Peura, Shoshana Joy Herzig, Takeshi Kamiya, Iva Pelosini, Carmelo Scarpignato, David Armstrong, Kenneth R. Devault, Paolo BechiAntonio Taddei, Giancarlo Freschi, Maria Novella Ringressi, Duccio Rossi Degli'Innocenti, Francesca Castiglione, Emmanuella Masini, Richard H. Hunt

Research output: Contribution to journalArticlepeer-review

Abstract

The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48-h pH monitoring, pH-impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery PPIs, immediate-release PPIs, long-term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti-inflammatory drugs (NSAIDs), and new PPIs.

Original languageEnglish
Pages (from-to)114-139
Number of pages26
JournalAnnals of the New York Academy of Sciences
Volume1232
Issue number1
DOIs
Publication statusPublished - Sep 2011

Keywords

  • 48-h acid reflux monitoring
  • ACG guidelines
  • Acid suppression
  • API-023
  • AspECT trial
  • Baclofen
  • Barrett's esophagus
  • Bile acids
  • Bilitec probe
  • Clostridium difficile
  • CMA omeprazole
  • COX-2 inhibitors
  • Dexlansoprazole
  • Erosive esophigitis
  • Functional dyspepsia
  • Functional heartburn
  • Fundic glands polyp
  • GABA
  • GERD
  • Ilaprazole
  • NERD
  • Nocturnal acid breakthrough
  • PH testing
  • Pharmacokinetic changes
  • PPI therapy
  • Rabeprazole
  • STU-Na
  • Symptom Association Probability
  • Tenatoprazole
  • TLESR

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Fingerprint Dive into the research topics of 'Barrett's esophagus: Proton pump inhibitors and chemoprevention II'. Together they form a unique fingerprint.

Cite this